Catalyst Wire Dossier Catalyst Wire Dossier

Aolanti Weikang Tablets

· Jiangxi Qingfeng Pharmaceutical Co. Ltd.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Aolanti Weikang Tablets, covering 2019-06-03 to 2019-06-03. Get the full timeline:

Most recent: Clinical Trial Update: Phase Ⅱc Sutdy of Aolanti Weikang Tablets in FD PDS Patients [Phase 2]

See pricing